retatrutide benefits clinical trials retatrutide phase approval: FDA status, trial results, and when it could be available Do not obsess over Retatrutide Dosing Schedule: From Clinical

PMID 25751285

Characteristics of included studies This meta-analysis analyzed seven retrospective cohort studies and 5,066,681 patients receiving GLP-1 RAs to evaluate their effects on colorectal cancer risk and incidence

The real key is going to be side effects over time, if retatrutide is like other drugs in the class then the side effects should decrease with time, but unfortunately, we dont have that today, at this point I have some questions and minor concerns but without the data over time its hard to speculate about tolerability further beyond saying its similar to other drugs in the class

Glutathione is a substance that is made in your body, and it is also the most common of the antioxidants